The present invention relates to a pharmaceutical composition containing a polypeptide having a PH domain of PHLDA family protein, to a pharmaceutical composition containing a DNA coding for a polypeptide having a PH domain of PHLDA family protein and to a pharmaceutical agent for the treatment of tumor containing those pharmaceutical compositions.

To access the rest of the information on this page,
Log In or sign up for a free B-Bridge account: